Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

AHA 2020 | In Most Cases, Imaging Can Determine What Causes MINOCA

Intravascular imaging with coronary optical coherence tomography (OCT) and magnetic resonance imaging allow for the identification of the cause of heart attack in 85% of women without coronary obstructions in angiography. 

Myocardial infarction with non-obstructive coronary arteries (MINOCA) affects women disproportionately and we have considered these events as “false positives” for far too long.

The HARP Study included 301 women, 170 of whom presented angina-like symptoms and troponin elevation without coronary obstruction (all below 50%). These 170 women were diagnosed with MINOCA.

Nuclear magnetic resonance imaging plus OCT allowed researchers to find the infarction mechanism in most of them.

OCT identified definitely or at least possibly culprit lesions with 6% plate rupture, 3% non-ruptured thrombus, 21% intra-plaque cavity, 13% dissected plaque, 2% intimal thickening/spasm, and 1% spontaneous dissection.


Read also: AHA 2020 | Rise in Early Discharge After TAVR Has the Expected Cost.


Magnetic resonance imaging showed ischemic patterns in most with myocardial edema in the culprit artery. A non-ischemic pattern was observed in 20.7% of patients, thus suggesting myocarditis, Tako Tsubo syndrome, or non-ischemic cardiomyopathy.

When the OCT and magnetic resonance findings are combined, it is possible to identify the cause of MINOCA in 84.5% of the cases.

Authors believe that intravascular ultrasound (IVUS) and tomography could play a role when magnetic resonance and OCT are not available.


Read also: AHA 2020 | The More Operators “Listen” to FFR, the Lower the Risk.


The 2020 European guidelines for infarction without ST-segment elevation provide a class IB recommendation for resonance imaging use in MINOCA. Resonance imaging was also recommended in the 2019 American guidelines.

None of these documents formally recommend OCT. They only suggest intravascular imaging could be useful if plaque rupture, plaque erosion, coronary dissection, etc., are suspected.

MINOCA

Original title: Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of MINOCA in women.

Reference: Reynolds HR et al. Presentado en el congreso AHA 2020 y publicado simultáneamente en Circulation. 2020 Nov 14. doi:10.1161/CIRCULATIONAHA.120.052008.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...